ID   NADC_HUMAN              Reviewed;         297 AA.
AC   Q15274; Q53XW7; Q96G22; Q9BSG6;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   18-MAY-2010, sequence version 3.
DT   15-MAR-2017, entry version 161.
DE   RecName: Full=Nicotinate-nucleotide pyrophosphorylase [carboxylating];
DE            EC=2.4.2.19;
DE   AltName: Full=Quinolinate phosphoribosyltransferase [decarboxylating];
DE            Short=QAPRTase;
DE            Short=QPRTase;
GN   Name=QPRT;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT ALA-195.
RC   TISSUE=Brain;
RX   PubMed=9473669; DOI=10.1016/S0167-4781(97)00143-7;
RA   Fukuoka S., Nyaruhucha C.M., Shibata K.;
RT   "Characterization and functional expression of the cDNA encoding human
RT   brain quinolinate phosphoribosyltransferase.";
RL   Biochim. Biophys. Acta 1395:192-201(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT ALA-195.
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT ALA-195.
RC   TISSUE=Kidney, Muscle, and Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [5]
RP   X-RAY CRYSTALLOGRAPHY (2.00 ANGSTROMS) IN COMPLEX WITH SUBSTRATE
RP   ANALOG, MUTAGENESIS OF ARG-102; ARG-138; LYS-139; ARG-161 AND LYS-171,
RP   FUNCTION, SUBUNIT, ENZYME REGULATION, AND BIOPHYSICOCHEMICAL
RP   PROPERTIES.
RX   PubMed=17868694; DOI=10.1016/j.jmb.2007.08.043;
RA   Liu H., Woznica K., Catton G., Crawford A., Botting N., Naismith J.H.;
RT   "Structural and kinetic characterization of quinolinate
RT   phosphoribosyltransferase (hQPRTase) from homo sapiens.";
RL   J. Mol. Biol. 373:755-763(2007).
RN   [6]
RP   VARIANT [LARGE SCALE ANALYSIS] ALA-195, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
CC   -!- FUNCTION: Involved in the catabolism of quinolinic acid (QA).
CC       {ECO:0000269|PubMed:17868694}.
CC   -!- CATALYTIC ACTIVITY: Beta-nicotinate D-ribonucleotide + diphosphate
CC       + CO(2) = pyridine-2,3-dicarboxylate + 5-phospho-alpha-D-ribose 1-
CC       diphosphate.
CC   -!- ENZYME REGULATION: Activity toward QA is slightly repressed by
CC       phosphoribosylpyrophosphate (PRPP) in both a competitive and a
CC       non-competitive manner. {ECO:0000269|PubMed:17868694}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=21 uM for QA (at 0.1 mM PRPP) {ECO:0000269|PubMed:17868694};
CC         KM=23 uM for QA (at 0.3 mM PRPP) {ECO:0000269|PubMed:17868694};
CC         Vmax=1.2 uM/min/mg enzyme (at 0.3 mM QA and 0.1 mM PRPP)
CC         {ECO:0000269|PubMed:17868694};
CC         Vmax=0.93 uM/min/mg enzyme (at 0.3 mM QA and 0.3 mM PRPP)
CC         {ECO:0000269|PubMed:17868694};
CC   -!- PATHWAY: Cofactor biosynthesis; NAD(+) biosynthesis; nicotinate D-
CC       ribonucleotide from quinolinate: step 1/1.
CC   -!- SUBUNIT: Hexamer formed by 3 homodimers.
CC       {ECO:0000269|PubMed:17868694}.
CC   -!- SIMILARITY: Belongs to the NadC/ModD family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; D78177; BAA11242.1; -; mRNA.
DR   EMBL; BT007231; AAP35895.1; -; mRNA.
DR   EMBL; BC005060; AAH05060.1; -; mRNA.
DR   EMBL; BC010033; AAH10033.1; -; mRNA.
DR   EMBL; BC018910; AAH18910.1; -; mRNA.
DR   CCDS; CCDS10651.1; -.
DR   PIR; T46864; T46864.
DR   RefSeq; NP_001305178.1; NM_001318249.1.
DR   RefSeq; NP_001305179.1; NM_001318250.1.
DR   RefSeq; NP_055113.2; NM_014298.4.
DR   UniGene; Hs.513484; -.
DR   UniGene; Hs.592544; -.
DR   UniGene; Hs.675754; -.
DR   PDB; 2JBM; X-ray; 2.00 A; A/B/C/D/E/F/G/H/I/J/K/L=1-297.
DR   PDB; 4KWV; X-ray; 2.80 A; A/B/C/D/E/F=1-297.
DR   PDB; 4KWW; X-ray; 2.55 A; A/B/C/D/E/F=1-297.
DR   PDB; 5AYX; X-ray; 2.80 A; A/B/C/D/E/F=1-297.
DR   PDB; 5AYY; X-ray; 3.09 A; A/B/C/D/E/F/G/H/I=1-297.
DR   PDB; 5AYZ; X-ray; 2.60 A; A/B/C/D/E/F/G/H/I/J/K/L=1-297.
DR   PDBsum; 2JBM; -.
DR   PDBsum; 4KWV; -.
DR   PDBsum; 4KWW; -.
DR   PDBsum; 5AYX; -.
DR   PDBsum; 5AYY; -.
DR   PDBsum; 5AYZ; -.
DR   ProteinModelPortal; Q15274; -.
DR   SMR; Q15274; -.
DR   BioGrid; 117035; 48.
DR   IntAct; Q15274; 6.
DR   MINT; MINT-1446481; -.
DR   STRING; 9606.ENSP00000378782; -.
DR   DrugBank; DB00627; Niacin.
DR   iPTMnet; Q15274; -.
DR   PhosphoSitePlus; Q15274; -.
DR   BioMuta; QPRT; -.
DR   DMDM; 296439291; -.
DR   EPD; Q15274; -.
DR   MaxQB; Q15274; -.
DR   PaxDb; Q15274; -.
DR   PeptideAtlas; Q15274; -.
DR   PRIDE; Q15274; -.
DR   DNASU; 23475; -.
DR   Ensembl; ENST00000395384; ENSP00000378782; ENSG00000103485.
DR   GeneID; 23475; -.
DR   KEGG; hsa:23475; -.
DR   UCSC; uc002dto.4; human.
DR   CTD; 23475; -.
DR   DisGeNET; 23475; -.
DR   GeneCards; QPRT; -.
DR   HGNC; HGNC:9755; QPRT.
DR   HPA; HPA011887; -.
DR   MIM; 606248; gene.
DR   neXtProt; NX_Q15274; -.
DR   OpenTargets; ENSG00000103485; -.
DR   PharmGKB; PA34096; -.
DR   eggNOG; KOG3008; Eukaryota.
DR   eggNOG; COG0157; LUCA.
DR   GeneTree; ENSGT00390000002761; -.
DR   HOGENOM; HOG000224023; -.
DR   HOVERGEN; HBG031727; -.
DR   InParanoid; Q15274; -.
DR   KO; K00767; -.
DR   OMA; DMIMLKD; -.
DR   OrthoDB; EOG091G10SF; -.
DR   PhylomeDB; Q15274; -.
DR   TreeFam; TF300845; -.
DR   BioCyc; MetaCyc:HS02508-MONOMER; -.
DR   BRENDA; 2.4.2.19; 2681.
DR   Reactome; R-HSA-196807; Nicotinate metabolism.
DR   UniPathway; UPA00253; UER00331.
DR   EvolutionaryTrace; Q15274; -.
DR   GenomeRNAi; 23475; -.
DR   PRO; PR:Q15274; -.
DR   Proteomes; UP000005640; Chromosome 16.
DR   Bgee; ENSG00000103485; -.
DR   CleanEx; HS_QPRT; -.
DR   ExpressionAtlas; Q15274; baseline and differential.
DR   Genevisible; Q15274; HS.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0004514; F:nicotinate-nucleotide diphosphorylase (carboxylating) activity; IDA:UniProtKB.
DR   GO; GO:0042803; F:protein homodimerization activity; IDA:UniProtKB.
DR   GO; GO:0009435; P:NAD biosynthetic process; IBA:GO_Central.
DR   GO; GO:0019674; P:NAD metabolic process; TAS:Reactome.
DR   GO; GO:0051259; P:protein oligomerization; IDA:UniProtKB.
DR   GO; GO:0034213; P:quinolinate catabolic process; IDA:UniProtKB.
DR   CDD; cd01572; QPRTase; 1.
DR   Gene3D; 3.20.20.70; -; 1.
DR   Gene3D; 3.90.1170.20; -; 1.
DR   InterPro; IPR013785; Aldolase_TIM.
DR   InterPro; IPR004393; NadC.
DR   InterPro; IPR027277; NadC/ModD.
DR   InterPro; IPR002638; Quinolinate_PRibosylTrfase_C.
DR   InterPro; IPR022412; Quinolinate_PRibosylTrfase_N.
DR   PANTHER; PTHR32179; PTHR32179; 1.
DR   Pfam; PF01729; QRPTase_C; 1.
DR   Pfam; PF02749; QRPTase_N; 1.
DR   PIRSF; PIRSF006250; NadC_ModD; 1.
DR   SUPFAM; SSF51690; SSF51690; 1.
DR   TIGRFAMs; TIGR00078; nadC; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Complete proteome; Glycosyltransferase; Polymorphism;
KW   Pyridine nucleotide biosynthesis; Reference proteome; Transferase.
FT   CHAIN         1    297       Nicotinate-nucleotide pyrophosphorylase
FT                                [carboxylating].
FT                                /FTId=PRO_0000155954.
FT   REGION      137    139       Substrate binding.
FT   REGION      248    250       Substrate binding. {ECO:0000250}.
FT   REGION      269    271       Substrate binding. {ECO:0000250}.
FT   BINDING     102    102       Substrate.
FT   BINDING     161    161       Substrate.
FT   BINDING     171    171       Substrate.
FT   BINDING     201    201       Substrate. {ECO:0000250}.
FT   BINDING     222    222       Substrate. {ECO:0000250}.
FT   VARIANT     158    158       A -> V (in dbSNP:rs2303255).
FT                                /FTId=VAR_021915.
FT   VARIANT     195    195       T -> A (in dbSNP:rs9932770).
FT                                {ECO:0000244|PubMed:21269460,
FT                                ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:9473669,
FT                                ECO:0000269|Ref.2}.
FT                                /FTId=VAR_050219.
FT   MUTAGEN     102    102       R->A,Q: Reduced activity.
FT                                {ECO:0000269|PubMed:17868694}.
FT   MUTAGEN     138    138       R->Q: Loss of activity.
FT                                {ECO:0000269|PubMed:17868694}.
FT   MUTAGEN     139    139       K->A,S: Loss of activity.
FT                                {ECO:0000269|PubMed:17868694}.
FT   MUTAGEN     161    161       R->A: Reduced activity.
FT                                {ECO:0000269|PubMed:17868694}.
FT   MUTAGEN     161    161       R->Q: Loss of activity.
FT                                {ECO:0000269|PubMed:17868694}.
FT   MUTAGEN     171    171       K->A,S: Loss of activity.
FT                                {ECO:0000269|PubMed:17868694}.
FT   CONFLICT     53     53       V -> I (in Ref. 2; AAP35895 and 3;
FT                                AAH05060). {ECO:0000305}.
FT   CONFLICT    170    170       V -> L (in Ref. 1; BAA11242).
FT                                {ECO:0000305}.
FT   CONFLICT    177    178       AA -> PP (in Ref. 1; BAA11242).
FT                                {ECO:0000305}.
FT   CONFLICT    208    208       A -> V (in Ref. 1; BAA11242).
FT                                {ECO:0000305}.
FT   CONFLICT    235    235       V -> A (in Ref. 1; BAA11242).
FT                                {ECO:0000305}.
FT   CONFLICT    276    276       A -> V (in Ref. 1; BAA11242).
FT                                {ECO:0000305}.
FT   HELIX         3      9       {ECO:0000244|PDB:2JBM}.
FT   HELIX        12     26       {ECO:0000244|PDB:2JBM}.
FT   HELIX        34     37       {ECO:0000244|PDB:2JBM}.
FT   STRAND       41     48       {ECO:0000244|PDB:2JBM}.
FT   STRAND       50     53       {ECO:0000244|PDB:5AYX}.
FT   HELIX        57     66       {ECO:0000244|PDB:2JBM}.
FT   STRAND       70     75       {ECO:0000244|PDB:2JBM}.
FT   STRAND       83     93       {ECO:0000244|PDB:2JBM}.
FT   HELIX        94    127       {ECO:0000244|PDB:2JBM}.
FT   STRAND      132    135       {ECO:0000244|PDB:2JBM}.
FT   HELIX       145    154       {ECO:0000244|PDB:2JBM}.
FT   TURN        161    163       {ECO:0000244|PDB:5AYX}.
FT   STRAND      166    170       {ECO:0000244|PDB:2JBM}.
FT   HELIX       172    178       {ECO:0000244|PDB:2JBM}.
FT   HELIX       181    192       {ECO:0000244|PDB:2JBM}.
FT   TURN        193    195       {ECO:0000244|PDB:2JBM}.
FT   STRAND      198    204       {ECO:0000244|PDB:2JBM}.
FT   HELIX       205    213       {ECO:0000244|PDB:2JBM}.
FT   STRAND      217    223       {ECO:0000244|PDB:2JBM}.
FT   HELIX       226    239       {ECO:0000244|PDB:2JBM}.
FT   STRAND      243    250       {ECO:0000244|PDB:2JBM}.
FT   TURN        253    255       {ECO:0000244|PDB:2JBM}.
FT   HELIX       256    259       {ECO:0000244|PDB:2JBM}.
FT   STRAND      266    268       {ECO:0000244|PDB:2JBM}.
FT   HELIX       271    274       {ECO:0000244|PDB:2JBM}.
FT   STRAND      281    288       {ECO:0000244|PDB:2JBM}.
SQ   SEQUENCE   297 AA;  30846 MW;  E3199814DB9FA0D5 CRC64;
     MDAEGLALLL PPVTLAALVD SWLREDCPGL NYAALVSGAG PSQAALWAKS PGVLAGQPFF
     DAIFTQLNCQ VSWFLPEGSK LVPVARVAEV RGPAHCLLLG ERVALNTLAR CSGIASAAAA
     AVEAARGAGW TGHVAGTRKT TPGFRLVEKY GLLVGGAASH RYDLGGLVMV KDNHVVAAGG
     VEKAVRAARQ AADFTLKVEV ECSSLQEAVQ AAEAGADLVL LDNFKPEELH PTATVLKAQF
     PSVAVEASGG ITLDNLPQFC GPHIDVISMG MLTQAAPALD FSLKLFAKEV APVPKIH
//
